Ldr Holding Corp (LDRH) 25.12 $LDRH
Nasdaq stocks posting largest percentage decreases
AP - Fri Apr 11, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
LDR Holding Corporation Issues Preliminary Results for First Quarter 2014
GlobeNewswire - Fri Apr 11, 7:52AM CDT
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced preliminary estimated financial results for the three months ended March 31, 2014. LDR expects that revenue, gross margin and operating loss will be in the following ranges:
LDR Files Registration Statement for Follow-on Offering
GlobeNewswire - Wed Apr 02, 4:49PM CDT
LDR Holding Corporation (Nasdaq:LDRH) ("LDR" or the "Company"
, a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC" relating to a proposed follow-on public offering of its common stock. The Company expects to raise approximately $25 million and selling stockholders expect to sell approximately 3.8 million shares of common stock in the offering, which share amount includes a 30-day option to purchase additional shares of common stock that is expected to be granted to the underwriters.
LDR Holding's Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 1:39PM CDT
LDR Holding's shares reached a 52-week high following the approval of Category I code.
Category I Code Approved for Two-Level Cervical Arthroplasty
GlobeNewswire - Tue Mar 11, 8:00AM CDT
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that the Current Procedural Terminology (CPT) Editorial Panel has accepted the addition of Category I code 22858X as an add-on code to support two-level cervical arthroplasty procedures. The coding change was recently disclosed on the American Medical Association (AMA) website and will become effective on January 1, 2015. Concurrent with this addition will be the elimination of the Category III code 0092T.
LDR Holding (LDRH) Enters Overbought Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 9:00AM CST
LDR Holding (LDRH) Enters Overbought Territory
LDR's VerteBRIDGE(R) Plating Technology Reaches New Milestone
GlobeNewswire - Fri Mar 07, 2:59AM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that there have been more than 50,000 implantations of its exclusive VerteBRIDGE plating technology worldwide. Since its introduction in 2007 in France and in 2008 in the United States, VerteBRIDGE technology has grown to a comprehensive platform of products with integrated, zero-profile, in-line plating technology adapted for use in anterior cervical, anterior lumbar, oblique lumbar, and lateral lumbar applications. LDR has experienced substantial and consistent growth with the ROI-C cervical cage and the ROI-A midline and oblique ALIF cages, and has seen early and significant adoption of the Avenue L lateral lumbar cage. The portfolio of cages with VerteBRIDGE technology has been used by surgeons around the world and continues to show great potential.
LDR Holding Corporation Reports Fourth Quarter and Fiscal Year 2013 Results
GlobeNewswire - Thu Feb 27, 3:51PM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today reported its financial results for the fourth quarter and year ended December 31, 2013.
LDR Holding Corporation Announces Fourth Quarter 2013 Conference Call
GlobeNewswire - Wed Feb 05, 4:00PM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that it will report financial results for the fourth quarter ended December 31, 2013 after the market close on Thursday, February 27, 2014. The Company also announced that it will host an investor conference call to discuss the results on the same day at 5:00 PM Eastern Time.
LDR Holding Corporation to Present at the Piper Jaffray 25th Annual Healthcare Conference
GlobeNewswire - Wed Nov 20, 5:00PM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that Christophe Lavigne, the Company's President and Chief Executive Officer, and Bob McNamara, the Company's Executive Vice President and Chief Financial Officer, will be presenting at the Piper Jaffray 25 Annual Healthcare Conference to be held on December 3-4 at the New York Palace Hotel in New York, NY.
LDR Holding Corporation Reports Third Quarter 2013 Results
GlobeNewswire - Wed Nov 06, 3:02PM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today reported its financial results for the third quarter and nine months ended September 30, 2013.
LDR Announces Presentation of Mobi-C(R) Cervical Disc Four Year Clinical Results at the North American Spine Society Annual Meeting
GlobeNewswire - Fri Oct 25, 7:00AM CDT
LDR Holding Corporation (Nasdaq:LDRH) ("LDR" or the "Company", a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, announced that Dr. Hyun Bae, Medical Director and Director of Spine Education at Cedars-Sinai in Los Angeles, CA presented 48-month safety and efficacy data of both one-level and two-level cervical disc replacement with Mobi-C compared to traditional anterior cervical discectomy and fusion (ACDF).
LDR Holding Corporation Announces Third Quarter 2013 Conference Call
GlobeNewswire - Thu Oct 24, 7:00AM CDT
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that it will report financial results for the third quarter ended September 30, 2013 after the market close on Wednesday, November 6, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 5:00 PM Eastern Time.
Nasdaq stocks posting largest percentage decreases
AP - Fri Apr 11, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
LDR Holding Corporation Issues Preliminary Results for First Quarter 2014
GlobeNewswire - Fri Apr 11, 7:52AM CDT
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced preliminary estimated financial results for the three months ended March 31, 2014. LDR expects that revenue, gross margin and operating loss will be in the following ranges:
LDR Files Registration Statement for Follow-on Offering
GlobeNewswire - Wed Apr 02, 4:49PM CDT
LDR Holding Corporation (Nasdaq:LDRH) ("LDR" or the "Company"
, a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC" relating to a proposed follow-on public offering of its common stock. The Company expects to raise approximately $25 million and selling stockholders expect to sell approximately 3.8 million shares of common stock in the offering, which share amount includes a 30-day option to purchase additional shares of common stock that is expected to be granted to the underwriters. LDR Holding's Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 1:39PM CDT
LDR Holding's shares reached a 52-week high following the approval of Category I code.
Category I Code Approved for Two-Level Cervical Arthroplasty
GlobeNewswire - Tue Mar 11, 8:00AM CDT
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that the Current Procedural Terminology (CPT) Editorial Panel has accepted the addition of Category I code 22858X as an add-on code to support two-level cervical arthroplasty procedures. The coding change was recently disclosed on the American Medical Association (AMA) website and will become effective on January 1, 2015. Concurrent with this addition will be the elimination of the Category III code 0092T.
LDR Holding (LDRH) Enters Overbought Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 9:00AM CST
LDR Holding (LDRH) Enters Overbought Territory
LDR's VerteBRIDGE(R) Plating Technology Reaches New Milestone
GlobeNewswire - Fri Mar 07, 2:59AM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that there have been more than 50,000 implantations of its exclusive VerteBRIDGE plating technology worldwide. Since its introduction in 2007 in France and in 2008 in the United States, VerteBRIDGE technology has grown to a comprehensive platform of products with integrated, zero-profile, in-line plating technology adapted for use in anterior cervical, anterior lumbar, oblique lumbar, and lateral lumbar applications. LDR has experienced substantial and consistent growth with the ROI-C cervical cage and the ROI-A midline and oblique ALIF cages, and has seen early and significant adoption of the Avenue L lateral lumbar cage. The portfolio of cages with VerteBRIDGE technology has been used by surgeons around the world and continues to show great potential.
LDR Holding Corporation Reports Fourth Quarter and Fiscal Year 2013 Results
GlobeNewswire - Thu Feb 27, 3:51PM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today reported its financial results for the fourth quarter and year ended December 31, 2013.
LDR Holding Corporation Announces Fourth Quarter 2013 Conference Call
GlobeNewswire - Wed Feb 05, 4:00PM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that it will report financial results for the fourth quarter ended December 31, 2013 after the market close on Thursday, February 27, 2014. The Company also announced that it will host an investor conference call to discuss the results on the same day at 5:00 PM Eastern Time.
LDR Holding Corporation to Present at the Piper Jaffray 25th Annual Healthcare Conference
GlobeNewswire - Wed Nov 20, 5:00PM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that Christophe Lavigne, the Company's President and Chief Executive Officer, and Bob McNamara, the Company's Executive Vice President and Chief Financial Officer, will be presenting at the Piper Jaffray 25 Annual Healthcare Conference to be held on December 3-4 at the New York Palace Hotel in New York, NY.
LDR Holding Corporation Reports Third Quarter 2013 Results
GlobeNewswire - Wed Nov 06, 3:02PM CST
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today reported its financial results for the third quarter and nine months ended September 30, 2013.
LDR Announces Presentation of Mobi-C(R) Cervical Disc Four Year Clinical Results at the North American Spine Society Annual Meeting
GlobeNewswire - Fri Oct 25, 7:00AM CDT
LDR Holding Corporation (Nasdaq:LDRH) ("LDR" or the "Company"
, a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, announced that Dr. Hyun Bae, Medical Director and Director of Spine Education at Cedars-Sinai in Los Angeles, CA presented 48-month safety and efficacy data of both one-level and two-level cervical disc replacement with Mobi-C compared to traditional anterior cervical discectomy and fusion (ACDF). LDR Holding Corporation Announces Third Quarter 2013 Conference Call
GlobeNewswire - Thu Oct 24, 7:00AM CDT
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, announced today that it will report financial results for the third quarter ended September 30, 2013 after the market close on Wednesday, November 6, 2013. The Company also announced that it will host an investor conference call to discuss the results on the same day at 5:00 PM Eastern Time.
